American Association for Cancer Research

sorry, we can't preview this file

mcr-23-0329_supplementary_figure_legends_1-6_supplementary_videos_1_and_2_suppsfl1.docx (15.87 kB)

Supplementary Figure Legends 1-6, Supplementary Videos 1 and 2 from Mitochondria Transfer by Platelet-Derived Microparticles Regulates Breast Cancer Bioenergetic States and Malignant Features

Download (15.87 kB)
journal contribution
posted on 2024-03-01, 12:40 authored by Vanessa Veilleux, Nicolas Pichaud, Luc H. Boudreau, Gilles A. Robichaud

Descriptions of supplementary data figures and videos


Canadian Cancer Society (CCS)

Canadian Institutes of Health Research (IRSC)

Natural Sciences and Engineering Research Council of Canada (NSERC)



An increasing number of studies show that platelets as well as platelet-derived microparticles (PMP) play significant roles in cancer malignancy and disease progression. Particularly, PMPs have the capacity to interact and internalize within target cells resulting in the transfer of their bioactive cargo, which can modulate the signaling and activation processes of recipient cells. We recently identified a new subpopulation of these vesicles (termed mitoMPs), which contain functional mitochondria. Given the predominant role of mitochondria in cancer cell metabolism and disease progression, we set out to investigate the impact of mitoMPs on breast cancer metabolic reprograming and phenotypic processes leading to malignancy. Interestingly, we observed that recipient cell permeability to PMP internalization varied among the breast cancer cell types evaluated in our study. Specifically, cells permissive to mitoMPs acquire mitochondrial-dependent functions, which stimulate increased cellular oxygen consumption rates and intracellular ATP levels. In addition, cancer cells co-incubated with PMPs display enhanced malignant features in terms of migration and invasion. Most importantly, the cancer aggressive processes and notable metabolic plasticity induced by PMPs were highly dependent on the functional status of the mitoMP-packaged mitochondria. These findings characterize a new mechanism by which breast cancer cells acquire foreign mitochondria resulting in the gain of metabolic processes and malignant features. A better understanding of these mechanisms may provide therapeutic opportunities through PMP blockade to deprive cancer cells from resources vital in disease progression. We show that the transfer of foreign mitochondria by microparticles modulates recipient cancer cell metabolic plasticity, leading to greater malignant processes.

Usage metrics

    Molecular Cancer Research



    Ref. manager